Drug Shortage Report for SANDOZ DORZOLAMIDE/TIMOLOL
Report ID | 232471 |
Drug Identification Number | 02344351 |
Brand name | SANDOZ DORZOLAMIDE/TIMOLOL |
Common or Proper name | DORZOLAMIDE/TIMOLOL |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | TIMOLOL DORZOLAMIDE |
Strength(s) | 5MG 20MG |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC OPHTHALMIC |
Packaging size | 10ML LDP |
ATC code | S01ED |
ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2024-07-08 |
Estimated end date | 2024-12-13 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-07-29 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2024-07-29 | French | Compare |
v4 | 2024-07-29 | English | Compare |
v3 | 2024-07-09 | English | Compare |
v2 | 2024-07-08 | French | Compare |
v1 | 2024-07-08 | English | Compare |
Showing 1 to 5 of 5